NMC
NEA Management Company’s Monte Rosa Therapeutics GLUE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34.7M | Hold |
7,692,298
| – | – | 2.61% | 10 |
|
2025
Q1 | $35.7M | Hold |
7,692,298
| – | – | 2.75% | 9 |
|
2024
Q4 | $53.4M | Hold |
7,692,298
| – | – | 3.01% | 10 |
|
2024
Q3 | $40.8M | Hold |
7,692,298
| – | – | 2.22% | 11 |
|
2024
Q2 | $28.8M | Hold |
7,692,298
| – | – | 2.16% | 11 |
|
2024
Q1 | $54.2M | Hold |
7,692,298
| – | – | 3.37% | 8 |
|
2023
Q4 | $43.5M | Hold |
7,692,298
| – | – | 2.9% | 9 |
|
2023
Q3 | $36.8M | Hold |
7,692,298
| – | – | 2.85% | 10 |
|
2023
Q2 | $52.7M | Hold |
7,692,298
| – | – | 4.02% | 9 |
|
2023
Q1 | $59.9M | Hold |
7,692,298
| – | – | 4.14% | 8 |
|
2022
Q4 | $58.5M | Sell |
7,692,298
-10,907
| -0.1% | -$83K | 3.29% | 11 |
|
2022
Q3 | $62.9M | Hold |
7,703,205
| – | – | 3.14% | 11 |
|
2022
Q2 | $74.5M | Hold |
7,703,205
| – | – | 3.83% | 8 |
|
2022
Q1 | $108M | Hold |
7,703,205
| – | – | 3.12% | 7 |
|
2021
Q4 | $157M | Hold |
7,703,205
| – | – | 3.18% | 7 |
|
2021
Q3 | $172M | Hold |
7,703,205
| – | – | 2.04% | 8 |
|
2021
Q2 | $175M | Buy |
+7,703,205
| New | +$175M | 2.28% | 8 |
|